FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Clonazepam Tablets
Status: Currently in Shortage
»Date first posted: 03/10/2023
»Therapeutic Categories: Neurology; Pediatric; Psychiatry

Expand all

Accord Healthcare, Inc. (New 03/10/2023)

Company Contact Information:
866-941-7875, option 2

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.5 mg, 100 count (NDC 16729-136-00)	Not available. Shortage duration not available.	Inventory on hold pending further assessment.	Other
0.5 mg, 500 count (NDC 16729-136-16)	Not available. Shortage duration not available.	Inventory on hold pending further assessment.	Other
1 mg, 100 count (NDC 16729-137-00)	Not available. Shortage duration not available.	Inventory on hold pending further assessment.	Other
1 mg, 500 count (NDC 16729-137-16)	Not available. Shortage duration not available.	Inventory on hold pending further assessment.	Other
2 mg, 100 count (NDC 16729-138-00)	Not available. Shortage duration not available.	Inventory on hold pending further assessment.	Other
2 mg, 500 count (NDC 16729-138-16)	Not available. Shortage duration not available.	Inventory on hold pending further assessment.	Other

Cheplapharm Arzneimittel GmbH (New 03/10/2023)

Company Contact Information:
orders@h2-pharma.com

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.5 mg, 100 count (NDC 61269-605-10)	Available	Marketed by H2-Pharma
1 mg, 100 count (NDC 61269-610-10)	Available	Marketed by H2-Pharma
2 mg, 100 count (NDC 61269-620-10)	Available	Marketed by H2-Pharma

Prinston Pharmaceutical, Inc. (New 03/10/2023)

Company Contact Information:
For orders, Solco Healthcare 866-931-9829

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.5 mg, 100 count (NDC 43547-406-10)	Available	Marketed by Solco Healthcare
0.5 mg, 1000 count (NDC 43547-406-11)	Available	Marketed by Solco Healthcare
0.5 mg, 500 count (NDC 43547-406-50)	Available	Marketed by Solco Healthcare
1 mg, 100 count (NDC 43547-407-10)	Available	Marketed by Solco Healthcare
1 mg, 1000 count (NDC 43547-407-11)	Available	Marketed by Solco Healthcare
1 mg, 500 count (NDC 43547-407-50)	Available	Marketed by Solco Healthcare
2 mg, 100 count (NDC 43547-408-10)	Available	Marketed by Solco Healthcare
2 mg, 500 count (NDC 43547-408-50)	Available	Marketed by Solco Healthcare

Rubicon Research Private Limited (Revised 04/12/2023)

Company Contact Information:
sales@advagenpharma.com

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.5 mg, 30 count (NDC 72888-152-30)	Available	Marketed by Advagen Pharma Ltd.
0.5 mg, 100 count (NDC 72888-152-01)	Available	Marketed by Advagen Pharma Ltd.
0.5 mg, 500 count (NDC 72888-152-05)	Available	Marketed by Advagen Pharma Ltd.
1 mg, 30 count (NDC 72888-153-30)	Available	Marketed by Advagen Pharma Ltd.
1 mg, 100 count (NDC 72888-153-01)	Available	Marketed by Advagen Pharma Ltd.
1 mg, 500 count (NDC 72888-153-05)	Available	Marketed by Advagen Pharma Ltd.
2 mg, 30 count (NDC 72888-154-30)	Available	Marketed by Advagen Pharma Ltd.
2 mg, 100 count (NDC 72888-154-01)	Available	Marketed by Advagen Pharma Ltd.
2 mg, 500 count (NDC 72888-154-05)	Available	Marketed by Advagen Pharma Ltd.

Teva Pharmaceuticals (Reverified 05/23/2023)

Company Contact Information:
800-545-8800

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
0.5 mg, 100 count (NDC 0093-0832-01)	Available
0.5 mg, 500 count (NDC 0093-0832-05)	Available
1 mg, 100 count (NDC 0093-3212-01)	Available
1 mg, 500 count (NDC 0093-3212-05)	Available
2 mg, 100 count (NDC 0093-3213-01)	Available
2 mg, 500 count (NDC 0093-3213-05)	Available